Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $13.38 in the prior trading day, Lyra Therapeutics Inc (NASDAQ: LYRA) closed at $9.11, down -31.91%. In other words, the price has decreased by -$31.91 from its previous closing price. On the day, 0.75 million shares were traded. LYRA stock price reached its highest trading level at $9.9487 during the session, while it also had its lowest trading level at $8.78.
Ratios:
Our goal is to gain a better understanding of LYRA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 2.96. In the meantime, Its Debt-to-Equity ratio is 8.62 whereas as Long-Term Debt/Eq ratio is at 7.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.
On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 25 ’25 when Waksal Harlan bought 145,370 shares for $0.10 per share.
Palasis Maria bought 39,567 shares of LYRA for $3,545 on Apr 09 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYRA now has a Market Capitalization of 12073847 and an Enterprise Value of 13694893. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.14 while its Price-to-Book (P/B) ratio in mrq is 3.10. Its current Enterprise Value per Revenue stands at 11.557 whereas that against EBITDA is -0.306.
Stock Price History:
The Beta on a monthly basis for LYRA is 0.36, which has changed by -0.386532 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, LYRA has reached a high of $37.50, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is 1.78%, while the 200-Day Moving Average is calculated to be -7.65%.
Shares Statistics:
The stock has traded on average 670.22K shares per day over the past 3-months and 198130 shares per day over the last 10 days, according to various share statistics. Insiders hold about 0.00% of the company’s shares, while institutions hold 36.57% stake in the company. Shares short for LYRA as of 1749772800 were 113755 with a Short Ratio of 0.17, compared to 1747267200 on 146567. Therefore, it implies a Short% of Shares Outstanding of 113755 and a Short% of Float of 10.74.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
